1
Nova University in Lisbon, Information management school, Lisbon, Portugal
(D20190535@novaims.unl.pt)
2
Nova University in Lisbon, Information management school, Lisbon, Portugal
(M20190508@novaims.unl.pt)
Abstract :
COVID-19, a coronavirus pandemic unlike any seen before, is in a state of flux over the planet. Since the COVID-19 pandemic now poses a serious danger to all nations, it is critical that policymakers find the most effective response possible. The coronavirus is difficult to eradicate, however the COVID-19 vaccination may help with that. Everyone is wondering which vaccination would be best for them. Multi-criteria decision-making (MCDM) is an excellent method for assessing this maze. As a result, we have suggested a cutting-edge MCDM method for choosing COVID-19 vaccinations. The primary objective of this work is to deliver a technique for MCDM. In this investigation, we present a unique hybrid model that combines the strengths of the neutrosophic Analytic Hierarchy Process (N-AHP) and the neutrosophic VIKOR technique. Using the N-AHP, we can quantify the importance of the criterion, and using the N-VIKOR method, we can prioritize our options for interventions.
Keywords :
MCDM; Neutrosophic Sets; Uncertainty; Single Valued Neutrosophic Sets;
References :
[1] I. M. Hezam, M. K. Nayeem, A. Foul, and A. F. Alrasheedi, “COVID-19 Vaccine: A neutrosophic MCDM
approach for determining the priority groups,” Results in physics, vol. 20, p. 103654, 2021.
[2] C. Kahraman, B. Oztaysi, and S. Cevik Onar, “Single & interval-valued neutrosophic AHP methods:
Performance analysis of outsourcing law firms,” Journal of Intelligent & Fuzzy Systems, vol. 38, no. 1,
pp. 749–759, 2020.
[3] M. Junaid, Y. Xue, M. W. Syed, J. Z. Li, and M. Ziaullah, “A neutrosophic ahp and topsis framework for
supply chain risk assessment in automotive industry of Pakistan,” Sustainability, vol. 12, no. 1, p. 154,
2019.
[4] L. Yang et al., “COVID-19: immunopathogenesis and Immunotherapeutics,” Signal transduction and
targeted therapy, vol. 5, no. 1, pp. 1–8, 2020.
[5] T. T. Le et al., “The COVID-19 vaccine development landscape,” Nat Rev Drug Discov, vol. 19, no. 5,
pp. 305–306, 2020.
[6] K. Yuki, M. Fujiogi, and S. Koutsogiannaki, “COVID-19 pathophysiology: A review,” Clinical
immunology, vol. 215, p. 108427, 2020.
[7] T. P. Velavan and C. G. Meyer, “The COVID‐19 epidemic,” Tropical medicine & international health,
vol. 25, no. 3, p. 278, 2020.
[8] Z. Andreadakis, A. Kumar, R. G. Román, S. Tollefsen, M. Saville, and S. Mayhew, “The COVID-19
vaccine development landscape,” Nat Rev Drug Discov, vol. 19, no. 5, pp. 305–306, 2020.
[9] M. Ciotti, M. Ciccozzi, A. Terrinoni, W.-C. Jiang, C.-B. Wang, and S. Bernardini, “The COVID-19
pandemic,” Critical reviews in clinical laboratory sciences, vol. 57, no. 6, pp. 365–388, 2020.
[10] X. Cao, “COVID-19: immunopathology and its implications for therapy,” Nature reviews immunology,
vol. 20, no. 5, pp. 269–270, 2020.
[11] J. H. Beigel et al., “Remdesivir for the treatment of Covid -19,” New England Journal of Medicine, vol.
383, no. 19, pp. 1813–1826, 2020.
[12] A. Sotoudeh-Anvari, “The applications of MCDM methods in COVID-19 pandemic: A state of the art
review,” Applied Soft Computing, p. 109238, 2022.
[13] P.-H. Nguyen, J.-F. Tsai, T.-T. Dang, M.-H. Lin, H.-A. Pham, and K.-A. Nguyen, “A hybrid spherical
fuzzy MCDM approach to prioritize governmental intervention strategies against the COVID -19
pandemic: A case study from Vietnam,” Mathematics, vol. 9, no. 20, p. 2626, 2021.
[14] R. Ghosh and F. N. Saima, “Resilience of commercial banks of Bangladesh to the shocks caused by
COVID-19 pandemic: an application of MCDM-based approaches,” Asian Journal of Accounting
Research, 2021.
[15] M. A. Alsalem et al., “Multi-criteria decision-making for coronavirus disease 2019 applications: A
theoretical analysis review,” Artificial Intelligence Review, pp. 1–84, 2022.
[16] N. Ahmad, M. G. Hasan, and R. K. Barbhuiya, “Identification and prioritization of strategies to tackle
COVID-19 outbreak: A group-BWM based MCDM approach,” Applied soft computing, vol. 111, p.
107642, 2021.
[17] C.-L. Lin, J. K. C. Chen, and H.-H. Ho, “BIM for smart hospital management during COVID-19 Using
MCDM,” Sustainability, vol. 13, no. 11, p. 6181, 2021.
[18] N. Aydin and S. Seker, “Determining the location of isolation hospitals for COVID‐19 via Delphi‐based
MCDM method,” International Journal of Intelligent Systems, vol. 36, no. 6, pp. 3011–3034, 2021.
[19] J. Hu, L. Pan, and X. Chen, “An interval neutrosophic projection-based VIKOR method for selecting
doctors,” Cognitive Computation, vol. 9, no. 6, pp. 801–816, 2017.
[20] J. Wang, G. Wei, and M. Lu, “An extended VIKOR method for multiple criteria group decision making
with triangular fuzzy neutrosophic numbers,” Symmetry, vol. 10, no. 10, p. 497, 2018.
[21] Y.-H. Huang, G.-W. Wei, and C. Wei, “VIKOR method for interval neutrosophic multiple attribute group
decision-making,” Information, vol. 8, no. 4, p. 144, 2017.
[22] H. Eroğlu and R. Şahin, “A neutrosophic VIKOR method-based decision-making with an improved
distance measure and score function: case study of selection for renewable energy alternatives,” Cognitive
Computation, vol. 12, no. 6, pp. 1338–1355, 2020.
[23] E. Bolturk and C. Kahraman, “A novel interval-valued neutrosophic AHP with cosine similarity measure,”
Soft Computing, vol. 22, no. 15, pp. 4941–4958, 2018.
[24] M. Yucesan and M. Gul, “Failure modes and effects analysis based on neutrosophic analytic hierarchy
process: method and application,” Soft Computing, vol. 25, no. 16, pp. 11035–11052, 2021.
[25] N. M. Radwan, M. B. Senousy, and M. R. Alaa El Din, Neutrosophic AHP multi criteria decision making
method applied on the selection of learning management system. Infinite Study, 2016.
| Style | # |
|---|---|
| MLA | Ahmed Abdelaziz, Alia Nabil Mahmoud. "COVID-19 vaccine choice using the multi-criteria decision making method under uncertainty." American Journal of Business and Operations Research, Vol. 8, No. 1, 2022 ,PP. 40-46 (Doi : https://doi.org/10.54216/AJBOR.080104) |
| APA | Ahmed Abdelaziz, Alia Nabil Mahmoud. (2022). COVID-19 vaccine choice using the multi-criteria decision making method under uncertainty. Journal of American Journal of Business and Operations Research, 8 ( 1 ), 40-46 (Doi : https://doi.org/10.54216/AJBOR.080104) |
| Chicago | Ahmed Abdelaziz, Alia Nabil Mahmoud. "COVID-19 vaccine choice using the multi-criteria decision making method under uncertainty." Journal of American Journal of Business and Operations Research, 8 no. 1 (2022): 40-46 (Doi : https://doi.org/10.54216/AJBOR.080104) |
| Harvard | Ahmed Abdelaziz, Alia Nabil Mahmoud. (2022). COVID-19 vaccine choice using the multi-criteria decision making method under uncertainty. Journal of American Journal of Business and Operations Research, 8 ( 1 ), 40-46 (Doi : https://doi.org/10.54216/AJBOR.080104) |
| Vancouver | Ahmed Abdelaziz, Alia Nabil Mahmoud. COVID-19 vaccine choice using the multi-criteria decision making method under uncertainty. Journal of American Journal of Business and Operations Research, (2022); 8 ( 1 ): 40-46 (Doi : https://doi.org/10.54216/AJBOR.080104) |
| IEEE | Ahmed Abdelaziz, Alia Nabil Mahmoud, COVID-19 vaccine choice using the multi-criteria decision making method under uncertainty, Journal of American Journal of Business and Operations Research, Vol. 8 , No. 1 , (2022) : 40-46 (Doi : https://doi.org/10.54216/AJBOR.080104) |